MELINTA THERAPEUTICS, INC. /NEW/ — key financial figures for fiscal year 2018 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2018)

$96.4M

Net Income/Loss (FY2018)

-$157.2M

Total Assets (FY2018)

$441.6M

Total Equity (FY2018)

$190.1M

Cash Flows from Operating Activities (FY2018)

-$171.5M

Source: MELINTA THERAPEUTICS, INC. /NEW/ 10-K filing (FY2018). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.